Vericel raises $65M in upsized follow-on

Cell therapy developer Vericel Corp. (NASDAQ:VCEL) raised $65 million through the sale of 5 million shares at $13 in a follow-on underwritten by Leerink, BTIG and Ladenburg Thalmann.

The price is a 7% discount from Vericel's closing price Wednesday, when it proposed after market hours to sell 3.8 million shares. The stock slipped $0.50 to $13.45 on Thursday and was up $0.95 to $14.40 on Friday. ...